dataHAL.science
Support
https://data.archives-ouvertes.fr/author/854064
https://data.archives-ouvertes.fr/author/854064
http://xmlns.com/foaf/0.1/topic_interest
Outcomes
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.sp.pharma
http://xmlns.com/foaf/0.1/name
Stéphane Oudard
http://xmlns.com/foaf/0.1/topic_interest
Immunotherapy
http://xmlns.com/foaf/0.1/topic_interest
Radioimmunotherapy
http://xmlns.com/foaf/0.1/topic_interest
Efficacy
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest
Chemotherapy
http://xmlns.com/foaf/0.1/topic_interest
Prognostic factor
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/info.info-bi
http://xmlns.com/foaf/0.1/topic_interest
Radiotherapy
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/stat.me
http://xmlns.com/foaf/0.1/topic_interest
Immune-related adverse events
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/math.math-st
http://xmlns.com/foaf/0.1/topic_interest
Adverse event
http://xmlns.com/foaf/0.1/topic_interest
Prostate cancer
http://xmlns.com/foaf/0.1/topic_interest
Taxanes
http://xmlns.com/foaf/0.1/topic_interest
Intensive care
http://xmlns.com/foaf/0.1/familyName
Oudard
http://xmlns.com/foaf/0.1/topic_interest
Biomarker
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.mhep.heg
http://xmlns.com/foaf/0.1/topic_interest
Cancer
http://xmlns.com/foaf/0.1/topic_interest
Hormone therapy
http://xmlns.com/foaf/0.1/topic_interest
Single nucleotide polymorphisms
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.mhep.un
http://xmlns.com/foaf/0.1/topic_interest
Angiogenesis inhibitor
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.mhep.phy
http://xmlns.com/foaf/0.1/topic_interest
Immune checkpoint inhibitor
http://xmlns.com/foaf/0.1/topic_interest
Immune checkpoint inhibitors
http://xmlns.com/foaf/0.1/topic_interest
Combination therapy
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.bibs
http://xmlns.com/foaf/0.1/topic_interest
Phytogenic/adverse effects Case-Control Studies Female Freezing Gloves
http://xmlns.com/foaf/0.1/topic_interest
Elderly
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.imm
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/info.info-gt
http://xmlns.com/foaf/0.1/topic_interest
Heterogeneity
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/scco.comp
http://xmlns.com/foaf/0.1/mbox_sha1sum
f7789e1b6f2d34d2ad025c9268368814
http://xmlns.com/foaf/0.1/topic_interest
Abiraterone acetate
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/info.info-mo
http://xmlns.com/foaf/0.1/topic_interest
Mitoxantrone
http://xmlns.com/foaf/0.1/topic_interest
Outcome
http://xmlns.com/foaf/0.1/topic_interest
French GETUG consortium
http://xmlns.com/foaf/0.1/topic_interest
Adult Aged Antineoplastic Agents
http://xmlns.com/foaf/0.1/topic_interest
Metastatic castration-resistant prostate cancer
http://xmlns.com/foaf/0.1/firstName
Stéphane
http://xmlns.com/foaf/0.1/topic_interest
Immunogenic cell death
http://xmlns.com/foaf/0.1/interest
https://data.archives-ouvertes.fr/subject/sdv.bc.ic
http://xmlns.com/foaf/0.1/topic_interest
Cancer treatment
http://xmlns.com/foaf/0.1/topic_interest
Prognosis
http://xmlns.com/foaf/0.1/topic_interest
Protective Humans Male Middle Aged Nail Diseases/chemically induced/prevention & control Skin Diseases/chemically induced/prevention & control Taxoids/adverse effects
http://xmlns.com/foaf/0.1/topic_interest
Small cell bladder cancer
https://aurehal.archives-ouvertes.fr/author/854064
Télécharger au format
RDF/XML
Turtle
N3
Json